Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ASX/EPN stock hub

ASX/EPN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/EPNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/EPN

In the news

Latest news · ASX/EPN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROEn/a

P25 -118.7P50 -49.4P75 -1.2

ROIC-15.1

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/EPN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

AUD

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 17.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	AU0000137598
Last refreshed	2026-05-10
Market cap	AUD 7.8M
Price	AUD 0.02
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/EPN
Website	https://epsilonhealthcare.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.43%
EV Earnings	-13.99x
EV/FCF	-5.43x
EV/Sales	1.9x
FCF yield	-42.36%
P/B ratio	4.07x
P/S ratio	0.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-23.27%
EBITDA Margin	-23.24%
Gross margin	60.1%
Gross Profit	AUD 5.6M
Gross Profit Growth	66.75%
Gross Profit Growth Q	123.16%
Gross Profit Growth3 Y	5.38%
Gross Profit Growth5 Y	15.67%
Net Income	AUD -1.3M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-23.9%
Profit Margin	-13.61%
ROA	-9.65
Roa5y	-14.67
ROCE	-16.49
ROIC	-15.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	67.74x
Revenue Growth Q	119.41x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	14.79x
Revenue Growth5 Y	14.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.66
Assets	AUD 17.9M
Cash	AUD 242,862
Current Assets	AUD 5.4M
Current Liabilities	AUD 4.6M
Debt	AUD 10.4M
Debt Equity	AUD 5.41
Debt FCF	AUD -3.14
Equity	AUD 1.9M
Interest Coverage	-1.99
Liabilities	AUD 16M
Long Term Assets	AUD 12.5M
Long Term Liabilities	AUD 11.3M
Net Cash	AUD -10.1M
Net Cash By Market Cap	AUD -130
Net Debt Equity	AUD 5.29
Tangible Book Value	AUD 1.9M
Tangible Book Value Per Share	AUD 0.01
WACC	8.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Inventory Turnover	4.32
Net Working Capital	AUD 1.1M
Quick ratio	0.84
Working Capital	AUD 765,014
Working Capital Turnover	AUD -54.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.02
All Time High	0.04
All Time High Change	-50%
All Time High Date	2025-12-22
All Time Low	0.02
All Time Low Change	5.26%
All Time Low Date	2026-05-05
ATR	0
Beta	0.7
Beta1y	-0.04
Beta2y	-0.02
Ch YTD	-39.39
High	0.02
High52	0.04
High52 Date	2025-12-30
High52ch	-50%
Low	0.02
Low52	0.02
Low52 Date	2026-05-05
Low52ch	5.26%
Ma50ch	-12.28%
RSI	36.31
RSI Monthly	0
RSI Weekly	9.96
Sharpe ratio	-1.18x
Sortino ratio	-1.63
Total Return	-9.77%
Tr YTD	-39.39
Tr1m	-9.09%
Tr3m	-37.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -2.2M
Operating margin	-23.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	254,042,252%
Net Borrowing	-5,157,483
Shares Insiders	11.84%
Shares Institutions	9.98%
Shares Out	389,104,011
Shares Qo Q	19.89%
Shares Yo Y	9.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -3.3M
Average Volume	257,409.4x
Bv Per Share	0.01
CAPEX	AUD -169,743
Ch1m	-9.09
Ch3m	-37.5
Change	0%
Change From Open	0
Close	0.02
Days Gap	0
Depreciation Amortization	2,850
Dollar Volume	6,503.8
Earnings Date	2026-05-29
EBIT	AUD -2.2M
EBITDA	AUD -2.2M
EPS	AUD -0
F Score	3
FCF	AUD -3.3M
FCF EV Yield	-18.43x
FCF Per Share	AUD -0.01
Financing CF	-4,482,383
Fiscal Year End	December
Founded	2,016
Income Tax	AUD -966,799
Investing CF	6,286,258
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma20	0.02
Ma20ch	-2.44%
Net CF	-1,322,785
Next Earnings Date	2026-05-29
Open	0.02
Position In Range	0
Ppne	12,158,093
Price Date	2026-05-07
Ptbv Ratio	4.07
Relative Volume	1.26x
Revenue	9,393,660x
Tax By Revenue	-10.29x
Volume	325,189
Z Score	-3.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/EPN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ASX/EPN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.0%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.8%

Negative means the company is buying back shares.

Technical

ASX/EPN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

-1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/EPN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/EPN stock rating?

asx/EPN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/EPN analysis?

The full report lives at /stocks/asx/EPN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/EPN?

The latest report frames asx/EPN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/EPN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.